Revvity

Revvity

Prezzo: 99.66

Società e modello di business

Revvity operates in the healthcare sector, focusing on providing advanced diagnostic and imaging solutions. Its core products include software and systems for medical imaging, data analytics, and patient management. Major business segments encompass diagnostic imaging, healthcare IT, and analytics services. The primary revenue sources are software sales, service contracts, and maintenance agreements.

Profilo di investimento

The stock is more aligned with value investors, given its modest dividend yield and recent revenue decline. It may appeal to those seeking stability rather than aggressive growth, reflecting a cautious investment approach. The investment profile suggests a focus on long-term value retention rather than short-term gains.

Sito ufficiale

Metriche fondamentali (sperimentale)

EPS (TTM) — utile per azione degli ultimi 12 mesi, $
2.10 OK
Ricavi QoQ — crescita dei ricavi trimestre su trimestre
-7.9%
Sorpresa EPS
3.9% in linea
Volatilità 20g
2.3% stabile
Rendimento dividendo
0.3% basso ultima data ex-dividendo: 2026-07-17
Dati FMP / FinFeed aggiornati: 2026-06-13
Racc.: Mantieni Potenziale: 55 Rischio: 64 Aggiornato: 2026-06-13 02:45
Come funziona la raccomandazione
Perché l'AI la pensa così:
Weak revenue growth raises concerns despite positive EPS surprise.

Traccia in portafoglio

Grafico prezzo

Raccomandazione AI Previsione analista Evento calendario Segnale positivo Segnale negativo Neutrale / aggiornamento Mantieni / informativo B My buy S My sell
Cambiamenti di raccomandazione AI
Data Prima Dopo Motivo
2026-05-26 03:32 Vendi Mantieni Weak fundamentals and mixed momentum signal caution.
2026-05-14 02:45 Mantieni Vendi Weak fundamentals and negative momentum raise concerns.
2026-05-08 15:18 Mantieni Mixed performance; watch for revenue recovery signs.
Previsioni analisti
Data Analista Action Target Prezzo allora
2026-05-06 11:21 Stifel Nicolaus Target abbassato 110 → 100 92.3
2026-05-06 10:52 Robert W. Baird Target abbassato 125 → 117 92.3
2026-05-04 10:26 Robert W. Baird Target abbassato 129 → 125 86.68

Ancora nulla